Instituto Nacional de Salud, Bogota, Colombia.
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Med Virol. 2021 Nov;93(11):6393-6397. doi: 10.1002/jmv.26815. Epub 2021 Feb 1.
We assessed maternal and infant cytomegalovirus (CMV) infection in Colombia. Maternal serum was tested for CMV immunoglobulin G antibodies at a median of 10 (interquartile range: 8-12) weeks gestation (n = 1501). CMV DNA polymerase chain reaction was performed on infant urine to diagnose congenital (≤21 days of life) and postnatal (>21 days) infection. Maternal CMV seroprevalence was 98.1% (95% confidence interval [CI]: 97.5%-98.8%). Congenital CMV prevalence was 8.4 (95% CI: 3.9%-18.3%; 6/711) per 1000 live births. Among 472 infants without confirmed congenital CMV infection subsequently tested at age 6 months, 258 (54.7%, 95% CI: 50.2%-59.1%) had postnatal infection.
我们评估了哥伦比亚的母婴巨细胞病毒(CMV)感染情况。在妊娠中位数为 10(四分位距:8-12)周时,对 1501 名孕妇的血清进行了 CMV 免疫球蛋白 G 抗体检测。对婴儿尿液进行 CMV 聚合酶链反应以诊断先天性(≤21 天)和产后(>21 天)感染。母体 CMV 血清阳性率为 98.1%(95%置信区间[CI]:97.5%-98.8%)。先天性 CMV 患病率为每 1000 例活产儿中有 8.4(95%CI:3.9%-18.3%;6/711)例。在随后在 6 个月大时对没有确诊先天性 CMV 感染的 472 名婴儿进行检测中,258 名(54.7%,95%CI:50.2%-59.1%)有产后感染。